{"id":"W3005570342","doi":"10.1634/theoncologist.2019-0674","title":"Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma","year":2020,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"Alberta Cancer Foundation","keywords":"Medicine; Nivolumab; Adverse effect; Pembrolizumab; Pneumonitis; Hazard ratio; Ipilimumab; Internal medicine; Melanoma; Cancer; Immunotherapy; Confidence interval; Lung","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005946474,0.0001440551,0.0001675588,0.0004045763,0.000191103,0.0003741862,0.000212548,0.0001769111,0.001585182],"category_scores_gemma":[0.001489399,0.00007583711,0.0002287536,0.0004936504,0.0002048115,0.0001768389,0.0002158673,0.0003153897,0.0001092967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007703303,"about_ca_system_score_gemma":0.000636083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009988662,"about_ca_topic_score_gemma":0.01959205,"domain_scores_codex":[0.9997736,0.00005274669,0.00001565244,0.00003939138,0.00007734496,0.0000413622],"domain_scores_gemma":[0.9983087,0.000192162,0.001140092,0.00003421431,0.0001492774,0.0001755856],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003763362,0.00003532461,0.992415,0.00004722616,0.00005902364,0.00005730372,0.00002510745,0.0002485256,0.0001958015,0.00001553765,0.0001500841,0.006374781],"study_design_scores_gemma":[0.00001124273,0.00009207483,0.9992381,0.00001022134,0.00002304858,0.0001654637,0.00001893839,0.0001719349,0.00005824386,0.00002030106,0.0001889202,0.000001506196],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969972,0.001709188,0.00007885926,0.00008983733,0.000004161137,0.000009603707,0.0003706885,0.000006171871,0.0007342214],"genre_scores_gemma":[0.9993271,0.0002497506,0.00004437545,0.00001962461,0.000007746758,0.000002862424,0.0002232367,7.59061e-7,0.0001246173],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009988662,"threshold_uncertainty_score":0.01986104,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03187919730524732,"score_gpt":0.3117223201264311,"score_spread":0.2798431228211838,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}